Showing 701-710 of 2159 results for "".
EHRs and the Regulatory Divide
https://practicaldermatology.com/topics/practice-management/ehrs-and-the-regulatory-divide/21343/EHRs, e-prescribing, and other digital technologies are becoming increasingly indifferent to government incentives.State Legislation of EHRs: A Sweeping Precedent?
https://practicaldermatology.com/topics/practice-management/state-ehr-legislation-a-new-precedent/21483/A new law in Massachusetts requires all licensed physicians to be using an EHR by 2015.RIP MU?
https://practicaldermatology.com/topics/practice-management/rip-mu/21010/Five ways to prepare for whatever comes next.Breaking the Red Tape: The AMA and Meaningful Use
https://practicaldermatology.com/topics/practice-management/breaking-the-red-tape-the-ama-and-meaningful-use/21096/New Findings Raise Questions About EHRs Going Forward
https://practicaldermatology.com/topics/practice-management/new-findings-raise-questions-about-ehrs-going-forward/22934/A recently published study dampens expectations for the future of EHRs, which may also signal diminished public support.EHRs in 2013: What are you Willing to Live With?
https://practicaldermatology.com/topics/practice-management/ehrs-in-2013-what-are-you-willing-to-live-with/22910/Satisfaction with EHRs could be defined by what hinders your workflow the least.New eRelevance Services, Cosmetic Bootcamp Updates, Leo & AID Partnership
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-new-erelevance-services-cosmetic-bootcamp-updates-leo-aid-partnership/18291/eRelevance has launched a suite of 4 services intended to support aesthetic practices in optimizing their marketing strategies to capture, convert, and retain patients. CEO Bob Fabbio discusses. Aesthetic education takes center stage at Cosmetic Boot Camp in Aspen. The meeting is open only to boardA Growing Biologics Armamentarium for Psoriasis and Atopic Dermatitis
https://practicaldermatology.com/topics/psoriasis/a-growing-biologics-armamentarium-for-psoriasis-and-atopic-dermatitis/20660/An overview of effective and safe treatment options that continue to come to market to target these chronic conditions.News
https://practicaldermatology.com/topics/general-topics/news/21280/News
https://practicaldermatology.com/topics/general-topics/news/21281/